COSSA's Analysis of FY 2025 Senate Bills

Read the full analysis.

COSSA's Annual Social Science Advocacy Day

Save the Date: March 24-25, 2025

Election 2024: Implications for Social and Behavioral Science Research

Why Social Science?

Because It Can Help Prepare Students for Employment

Your Voice for Social Science in Washington 

The Consortium of Social Science Associations (COSSA) is a nonprofit advocacy organization working to promote and advance the social and behavioral sciences in federal policymaking. Headquartered in Washington, DC, COSSA serves as a united voice for organizations, institutions, communities, and stakeholders who care about a successful and vibrant social science research enterprise. COSSA’s policy experts work with a broad network of advocates to ensure sustainable federal funding for social and behavioral science research and the widespread use of our sciences in policymaking. Join our team of professional associations, scientific societies, research centers and institutes, U.S. colleges and universities, and private sector partners to help raise the profile of social and behavioral science research.

Featured News

from the COSSA Washington Update

Featured News

from the COSSA Washington Update

Administration Expands Ban on “Promotion” of Structural Racism/Sexism to Contractors, Grantees

As part of the Administration’s ongoing effort to crack down on perceived “political correctness” in government, President Trump issued an executive order on September 22 to “combat offensive and anti-American…

Remembering James Jackson (1944-2020)

Dr. James S. Jackson, renown social psychologist and Daniel Katz Distinguished University Professor of Psychology, Emeritus, at the University of Michigan, Ann Arbor, passed away on September 1. A pioneer…

National Academies Study on COVID-19 Vaccine Allocation Releases Discussion Draft, Seeks Feedback (Short Turnaround)

The National Academies of Sciences, Engineering, and Medicine (NASEM) has released a discussion draft of a Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, part of a fast-track study initiated…